Diabetes

In type 1 diabetes, the immune system attacks insulin-producing pancreatic cells, while type 2 diabetes often involves inflammation that worsens insulin resistance. Stem cells can modulate the immune response to protect pancreatic cells in type 1 diabetes and reduce inflammation in type 2, potentially improving insulin sensitivity. CellMark360’s technology isolates your stem cells to support pancreatic repair and metabolic health, offering a new approach to diabetes management.

How Your Own Stem Cells Support Healing for Diabetes

Heals Chronic Diabetic Ulcers

Autologous SVF has helped over 90% of patients with non-healing diabetic foot ulcers achieve full healing, potentially avoiding amputations by promoting tissue regeneration and angiogenesis.

Improves Blood Sugar Control

Studies show that both SVF and ADSCs can reduce HbA1c levels, helping patients achieve better glycemic control naturally—often with reduced insulin requirements.

Boosts Circulation and Oxygenation

SVF increases microvascular blood flow and oxygen levels in diabetic limbs, improving the environment for healing and reducing complications like infection and tissue death.

Safe, Personalized, and Minimally Invasive

Using your own fat-derived stem cells means no immune rejection risk. The outpatient procedure is quick, and studies report a strong safety profile—even in high-risk diabetic patients.

Research confirms ADSCs reduce inflammation, repair cartilage, and improve function.

Carstens et al. – SVF for Diabetic Foot Ulcers

Study Summary:

63 patients with chronic DFUs (non-healing ulcers) and amputation risk received 30M SVF cells in affected areas.

Results:

*At 6 months: 86% had full closure; all others saw ≥75% improvement

*At 12 months: 93% achieved complete healing

*Improved arterial blood flow in all Doppler-tested vessels

(Source: PubMed)

SVF Microcirculation Study – Improved Oxygenation

Study Summary:

10 diabetic feet were treated with subcutaneous SVF injections around wounds.

Results at 12 weeks:

*TcPO₂ increased from 31.3 to 46.4 mmHg

*Blood flow more than doubled

*No adverse events reported

(Source: IJSC)

Learn more

Interested in Personal Stem Cell Therapy?